Published in Elife on April 22, 2014
The mechanism of RNA 5′ capping with NAD+, NADH and desphospho-CoA. Nature (2016) 1.50
Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase. Cell (2017) 1.39
Structural basis of transcription initiation by bacterial RNA polymerase holoenzyme. J Biol Chem (2014) 1.17
Structural biology of bacterial RNA polymerase. Biomolecules (2015) 0.91
Structures of E. coli σS-transcription initiation complexes provide new insights into polymerase mechanism. Proc Natl Acad Sci U S A (2016) 0.85
Uncoupling Promoter Opening from Start-Site Scanning. Mol Cell (2015) 0.84
Structural Basis of Transcription Inhibition by CBR Hydroxamidines and CBR Pyrazoles. Structure (2015) 0.80
Relationships of RNA polymerase II genetic interactors to transcription start site usage defects and growth in Saccharomyces cerevisiae. G3 (Bethesda) (2014) 0.78
X-ray crystal structures of Escherichia coli RNA polymerase with switch region binding inhibitors enable rational design of squaramides with an improved fraction unbound to human plasma protein. J Med Chem (2015) 0.78
Mutations in the CRE pocket of bacterial RNA polymerase affect multiple steps of transcription. Nucleic Acids Res (2015) 0.78
Structural basis for rifamycin resistance of bacterial RNA polymerase by the three most clinically important RpoB mutations found in Mycobacterium tuberculosis. Mol Microbiol (2016) 0.77
Bacterial RNA Polymerase-DNA Interaction-The Driving Force of Gene Expression and the Target for Drug Action. Front Mol Biosci (2016) 0.77
A model for genesis of transcription systems. Transcription (2016) 0.77
Bacterial Transcription as a Target for Antibacterial Drug Development. Microbiol Mol Biol Rev (2016) 0.77
Kinetics of nucleotide entry into RNA polymerase active site provides mechanism for efficiency and fidelity. Biochim Biophys Acta (2017) 0.75
A new spanner in the works of bacterial transcription. Elife (2014) 0.75
Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition. Mol Cell (2017) 0.75
RNA polymerase molecular beacon as tool for studies of RNA polymerase-promoter interactions. Methods (2015) 0.75
PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr (2010) 108.52
Phaser crystallographic software. J Appl Crystallogr (2007) 108.34
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A (2000) 96.90
Features and development of Coot. Acta Crystallogr D Biol Crystallogr (2010) 89.46
Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr (2005) 61.38
MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr (2009) 53.36
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res (2007) 37.31
iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr D Biol Crystallogr (2011) 18.13
Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J Mol Biol (1988) 8.26
Mode of action of rafamycin on the RNA polymerase reaction. Biochim Biophys Acta (1968) 8.01
Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2006) 7.29
Factors involved in specific transcription by human RNA polymerase II: analysis by a rapid and quantitative in vitro assay. Proc Natl Acad Sci U S A (1985) 6.94
Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell (2001) 6.10
Structural basis for substrate loading in bacterial RNA polymerase. Nature (2007) 4.40
Prokaryotic and eukaryotic RNA polymerases have homologous core subunits. Proc Natl Acad Sci U S A (1987) 3.80
Abortive initiation and productive initiation by RNA polymerase involve DNA scrunching. Science (2006) 3.76
Structural basis of transcription: nucleotide selection by rotation in the RNA polymerase II active center. Cell (2004) 3.34
Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase. J Biol Chem (1993) 3.07
Transcription activation at class II CAP-dependent promoters: two interactions between CAP and RNA polymerase. Cell (1996) 2.88
Inhibition of bacterial RNA polymerase by streptolydigin: stabilization of a straight-bridge-helix active-center conformation. Cell (2005) 2.88
A central role of the RNA polymerase trigger loop in active-site rearrangement during transcriptional pausing. Mol Cell (2007) 2.80
On the mechanism of rifampicin inhibition of RNA synthesis. J Biol Chem (1978) 2.55
Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome. DNA Repair (Amst) (2003) 2.52
Structural basis of transcription initiation. Science (2012) 2.23
Characterization of ribonucleic acid polymerase-T7 promoter binary complexes. Biochemistry (1980) 2.22
Recombineering: in vivo genetic engineering in E. coli, S. enterica, and beyond. Methods Enzymol (2007) 2.21
Translocation of sigma(70) with RNA polymerase during transcription: fluorescence resonance energy transfer assay for movement relative to DNA. Cell (2001) 2.17
Amino acid changes in conserved regions of the beta-subunit of Escherichia coli RNA polymerase alter transcription pausing and termination. Genes Dev (1990) 2.06
RNA polymerase rifampicin resistance mutations in Escherichia coli: sequence changes and dominance. Mol Gen Genet (1983) 1.98
The RNA polymerase "switch region" is a target for inhibitors. Cell (2008) 1.96
Discontinuous movements of DNA and RNA in RNA polymerase accompany formation of a paused transcription complex. Cell (1995) 1.96
Searching sequence space by definably random mutagenesis: improving the catalytic potency of an enzyme. Proc Natl Acad Sci U S A (1990) 1.92
Location, structure, and function of the target of a transcriptional activator protein. Genes Dev (1994) 1.88
Antibacterial peptide microcin J25 inhibits transcription by binding within and obstructing the RNA polymerase secondary channel. Mol Cell (2004) 1.80
Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase. EMBO J (2005) 1.71
A new class of bacterial RNA polymerase inhibitor affects nucleotide addition. Science (2003) 1.63
Primary structure of Escherichia coli RNA polymerase nucleotide substitution in the beta subunit gene of the rifampicin resistant rpoB255 mutant. Mol Gen Genet (1981) 1.54
RifR mutations in the beginning of the Escherichia coli rpoB gene. Mol Gen Genet (1994) 1.52
Transcriptional infidelity promotes heritable phenotypic change in a bistable gene network. PLoS Biol (2009) 1.48
Mapping of the priming substrate contacts in the active center of Escherichia coli RNA polymerase. J Biol Chem (1991) 1.41
Streptolydigin-resistant mutants in an evolutionarily conserved region of the beta' subunit of Escherichia coli RNA polymerase. J Biol Chem (1995) 1.38
A reliable method for random mutagenesis: the generation of mutant libraries using spiked oligodeoxyribonucleotide primers. Gene (1989) 1.35
Supercoiling response of the lac ps promoter in vitro. J Mol Biol (1985) 1.35
Structures of RNA polymerase-antibiotic complexes. Curr Opin Struct Biol (2009) 1.28
The sorangicins, novel and powerful inhibitors of eubacterial RNA polymerase isolated from myxobacteria. J Antibiot (Tokyo) (1987) 1.28
New target for inhibition of bacterial RNA polymerase: 'switch region'. Curr Opin Microbiol (2011) 1.26
Blocking of the initiation-to-elongation transition by a transdominant RNA polymerase mutation. Science (1990) 1.24
Four contiguous amino acids define the target for streptolydigin resistance in the beta subunit of Escherichia coli RNA polymerase. J Biol Chem (1993) 1.21
The involvement of the aspartate triad of the active center in all catalytic activities of multisubunit RNA polymerase. Nucleic Acids Res (2005) 1.19
Chemical modifications and biological properties of rifamycins. Antimicrob Agents Chemother (Bethesda) (1966) 1.17
Quorum-sensing-dependent regulation of biosynthesis of the polyketide antibiotic mupirocin in Pseudomonas fluorescens NCIMB 10586. Microbiology (2001) 1.17
Rifamycins do not function by allosteric modulation of binding of Mg2+ to the RNA polymerase active center. Proc Natl Acad Sci U S A (2008) 1.16
Tethering of the large subunits of Escherichia coli RNA polymerase. J Biol Chem (1997) 1.16
Lipiarmycin, a new antibiotic from Actinoplanes. II. Isolation, chemical, biological and biochemical characterization. J Antibiot (Tokyo) (1975) 1.14
The nucleotide addition cycle of RNA polymerase is controlled by two molecular hinges in the Bridge Helix domain. BMC Biol (2010) 1.11
Evolution of Escherichia coli rifampicin resistance in an antibiotic-free environment during thermal stress. BMC Evol Biol (2013) 1.09
Structural basis of transcription elongation. Biochim Biophys Acta (2012) 1.09
Dominant lethal mutations near the 5' substrate binding site affect RNA polymerase propagation. J Biol Chem (1993) 1.08
Distance-restrained docking of rifampicin and rifamycin SV to RNA polymerase using systematic FRET measurements: developing benchmarks of model quality and reliability. Biophys J (2004) 1.03
Site-specific protein-DNA photocrosslinking. Analysis of bacterial transcription initiation complexes. Methods Mol Biol (2001) 0.98
Cross-resistance of Escherichia coli RNA polymerases conferring rifampin resistance to different antibiotics. J Bacteriol (2005) 0.95
Activity map of the Escherichia coli RNA polymerase bridge helix. J Biol Chem (2011) 0.94
Mode of action of the microbial metabolite GE23077, a novel potent and selective inhibitor of bacterial RNA polymerase. Eur J Biochem (2004) 0.93
Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. I. Taxonomy, isolation and characterization. J Antibiot (Tokyo) (2004) 0.90
Transcriptional proofreading in Escherichia coli. EMBO J (1989) 0.89
Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. Part 3: Chemical derivatization. Bioorg Med Chem Lett (2005) 0.87
A fluorescence-based assay for multisubunit DNA-dependent RNA polymerases. Anal Biochem (2004) 0.86
[Nucleotide substitutions in the rpoB gene leading to rifampicin resistance of E. coli RNA polymerase]. Bioorg Khim (1984) 0.86
[Localization of mutation leading to resistance of E. coli RNA polymerase to the antibiotic streptolydigin in the gene rpoB coding for the beta-subunit of the enzyme]. Bioorg Khim (1985) 0.81
Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. II. Structure elucidation. J Antibiot (Tokyo) (2005) 0.76
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science (2010) 14.91
Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity. J Biol Chem (2004) 6.55
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38
Dynamically driven protein allostery. Nat Struct Mol Biol (2006) 4.53
Initial transcription by RNA polymerase proceeds through a DNA-scrunching mechanism. Science (2006) 4.36
Abortive initiation and productive initiation by RNA polymerase involve DNA scrunching. Science (2006) 3.76
Accurate FRET measurements within single diffusing biomolecules using alternating-laser excitation. Biophys J (2005) 3.22
Structural organization of bacterial RNA polymerase holoenzyme and the RNA polymerase-promoter open complex. Cell (2002) 3.21
HEN1 recognizes 21-24 nt small RNA duplexes and deposits a methyl group onto the 2' OH of the 3' terminal nucleotide. Nucleic Acids Res (2006) 3.14
Catabolite activator protein: DNA binding and transcription activation. Curr Opin Struct Biol (2004) 2.91
Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition. J Mol Biol (2008) 2.88
Inhibition of bacterial RNA polymerase by streptolydigin: stabilization of a straight-bridge-helix active-center conformation. Cell (2005) 2.88
High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations. Proc Natl Acad Sci U S A (2008) 2.82
Structural basis of transcription activation: the CAP-alpha CTD-DNA complex. Science (2002) 2.67
Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA. EMBO J (2002) 2.41
Structural basis for cAMP-mediated allosteric control of the catabolite activator protein. Proc Natl Acad Sci U S A (2009) 2.39
Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01. J Virol (2011) 2.34
Structures of influenza A proteins and insights into antiviral drug targets. Nat Struct Mol Biol (2010) 2.31
In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine). J Med Chem (2005) 2.31
Structural basis of transcription initiation. Science (2012) 2.23
An open letter to Elias Zerhouni. Science (2005) 2.19
Structural basis for suppression of a host antiviral response by influenza A virus. Proc Natl Acad Sci U S A (2008) 2.02
The RNA polymerase "switch region" is a target for inhibitors. Cell (2008) 1.96
Retention of transcription initiation factor sigma70 in transcription elongation: single-molecule analysis. Mol Cell (2005) 1.96
Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors. Prog Biophys Mol Biol (2005) 1.93
Direct observation of abortive initiation and promoter escape within single immobilized transcription complexes. Biophys J (2005) 1.90
HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel site. ACS Chem Biol (2006) 1.83
Promoter unwinding and promoter clearance by RNA polymerase: detection by single-molecule DNA nanomanipulation. Proc Natl Acad Sci U S A (2004) 1.81
The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro. J Virol (2003) 1.80
Antibacterial peptide microcin J25 inhibits transcription by binding within and obstructing the RNA polymerase secondary channel. Mol Cell (2004) 1.80
Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir. Nat Struct Mol Biol (2004) 1.78
The sigma 70 subunit of RNA polymerase mediates a promoter-proximal pause at the lac promoter. Nat Struct Mol Biol (2004) 1.77
Antibiotic discovery in the twenty-first century: current trends and future perspectives. J Antibiot (Tokyo) (2010) 1.74
Opening and closing of the bacterial RNA polymerase clamp. Science (2012) 1.73
Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase. EMBO J (2005) 1.71
Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates. J Exp Med (2010) 1.63
Thermodynamic and kinetic modeling of transcriptional pausing. Proc Natl Acad Sci U S A (2006) 1.61
Two-dimensional infrared spectra reveal relaxation of the nonnucleoside inhibitor TMC278 complexed with HIV-1 reverse transcriptase. Proc Natl Acad Sci U S A (2007) 1.61
PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4. J Virol (2012) 1.58
Structural and molecular interactions of CCR5 inhibitors with CCR5. J Biol Chem (2006) 1.55
Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design. Nucleic Acids Res (2008) 1.54
Direct detection of abortive RNA transcripts in vivo. Science (2009) 1.53
HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism. Nat Struct Mol Biol (2012) 1.52
Structure of antibacterial peptide microcin J25: a 21-residue lariat protoknot. J Am Chem Soc (2003) 1.51
The mechanism of RNA 5′ capping with NAD+, NADH and desphospho-CoA. Nature (2016) 1.50
Structural basis of HIV-1 resistance to AZT by excision. Nat Struct Mol Biol (2010) 1.50
Structure of HIV-1 reverse transcriptase with the inhibitor beta-Thujaplicinol bound at the RNase H active site. Structure (2009) 1.50
Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains. J Med Chem (2005) 1.48
Single-molecule DNA nanomanipulation: improved resolution through use of shorter DNA fragments. Nat Methods (2005) 1.47
High-resolution definition of vaccine-elicited B cell responses against the HIV primary receptor binding site. Sci Transl Med (2012) 1.45
Response of RNA polymerase to ppGpp: requirement for the omega subunit and relief of this requirement by DksA. Genes Dev (2005) 1.45
Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases. Curr Opin Struct Biol (2004) 1.44
Chlorotonil A, a macrolide with a unique gem-dichloro-1,3-dione functionality from Sorangium cellulosum, So ce1525. Angew Chem Int Ed Engl (2008) 1.43
Trapping HIV-1 reverse transcriptase before and after translocation on DNA. J Biol Chem (2003) 1.41
The initiation factor TFE and the elongation factor Spt4/5 compete for the RNAP clamp during transcription initiation and elongation. Mol Cell (2011) 1.40
The interaction between sigma70 and the beta-flap of Escherichia coli RNA polymerase inhibits extension of nascent RNA during early elongation. Proc Natl Acad Sci U S A (2005) 1.38
Experimental and theoretical studies of nanofluid thermal conductivity enhancement: a review. Nanoscale Res Lett (2011) 1.38
Structural basis for the role of the K65R mutation in HIV-1 reverse transcriptase polymerization, excision antagonism, and tenofovir resistance. J Biol Chem (2009) 1.37
2'-deoxy-4'-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants. Int J Biochem Cell Biol (2008) 1.36
Efficacy of the new lantibiotic NAI-107 in experimental infections induced by multidrug-resistant Gram-positive pathogens. Antimicrob Agents Chemother (2011) 1.35
Determinants of the C-terminal domain of the Escherichia coli RNA polymerase alpha subunit important for transcription at class I cyclic AMP receptor protein-dependent promoters. J Bacteriol (2002) 1.33
Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097. J Mol Biol (2006) 1.31
Functional interaction between RNA polymerase alpha subunit C-terminal domain and sigma70 in UP-element- and activator-dependent transcription. Mol Cell (2003) 1.31
Crystal structures of arginine deiminase with covalent reaction intermediates; implications for catalytic mechanism. Structure (2004) 1.30
Structures of RNA polymerase-antibiotic complexes. Curr Opin Struct Biol (2009) 1.28
Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability. J Med Chem (2005) 1.28
New target for inhibition of bacterial RNA polymerase: 'switch region'. Curr Opin Microbiol (2011) 1.26
Three-dimensional EM structure of an intact activator-dependent transcription initiation complex. Proc Natl Acad Sci U S A (2009) 1.26
Rescue of progranulin deficiency associated with frontotemporal lobar degeneration by alkalizing reagents and inhibition of vacuolar ATPase. J Neurosci (2011) 1.26
Snapshot of the equilibrium dynamics of a drug bound to HIV-1 reverse transcriptase. Nat Chem (2013) 1.24